Pegunigalsidase Alfa

Records for this ingredient, by country (identity only).

ATC A16AB20 · 7 markets · 12 records

Pegunigalsidase Alfa 7 markets · 12 records Forms
Filters

AU 3 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 20 mg/10 mLinjectionELFABRIO also in US·GB
  • 20 mg per mL / per unit basis not statedinjectionELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 2 mg/mL per mL / per unit basis not statedinjectionElfabrio Concentrate for Solution for Infusion 2 mg/ml

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.